347850.KQ
D&D Pharmatech
KOE · Healthcare · Biotechnology · KR
KRW 48,500.00
−1.12%Margins
Gross margin
-56.6%
EBITDA margin
-1103.0%
EBIT margin
-1367.9%
Net margin
-785.5%
FCF margin
-906.6%
-16.0%
Return on equity
-6.8%
Return on assets
-15.1%
Return on invested capital
0.01x
Asset turnover
-KRW 24.9B
Cash from operations
KRW 2.6K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026